These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 3118117)

  • 1. Immunofluorescence labeling indices in myeloma and related monoclonal gammopathies.
    Greipp PR; Witzig TE; Gonchoroff NJ; Habermann TM; Katzmann JA; O'Fallon WM; Kyle RA
    Mayo Clin Proc; 1987 Nov; 62(11):969-77. PubMed ID: 3118117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Capillary Electrophoresis in Monoclonal Gammopathies and the Cutoff Value of Monoclonal Protein in Differential Diagnosis of Multiple Myeloma and Other Monoclonal Gammopathies.
    Cao F; Zhang R; Xu L; Liu M; Yuan Y
    Ann Clin Lab Sci; 2021 May; 51(3):400-407. PubMed ID: 34162571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign and malignant monoclonal gammopathies.
    Carney DN; Bunn PA
    Prim Care; 1980 Sep; 7(3):369-94. PubMed ID: 6777792
    [No Abstract]   [Full Text] [Related]  

  • 4. Peripheral blood B cell labeling indices are a measure of disease activity in patients with monoclonal gammopathies.
    Witzig TE; Gonchoroff NJ; Katzmann JA; Therneau TM; Kyle RA; Greipp PR
    J Clin Oncol; 1988 Jun; 6(6):1041-6. PubMed ID: 3286829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio.
    Prokaeva T; Spencer B; Sun F; O'Hara RM; Seldin DC; Connors LH; Sanchorawala V
    Amyloid; 2016 Dec; 23(4):214-220. PubMed ID: 27677679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunofluorescent plasma cell labeling indices (LI) using a monoclonal antibody (BU-1).
    Greipp PR; Witzig TE; Gonchoroff NJ
    Am J Hematol; 1985 Nov; 20(3):289-92. PubMed ID: 3904417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions.
    Milani P; Palladini G; Merlini G
    Scand J Clin Lab Invest Suppl; 2016; 245():S113-8. PubMed ID: 27467897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnostic problems in monoclonal gammopathies].
    Tilz GP; Becker H; Lanzer G
    Acta Med Austriaca; 1982; 9(4):139-42. PubMed ID: 6814156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of free light chains with assays based on monoclonal antibodies.
    Te Velthuis H; Drayson M; Campbell JP
    Clin Chem Lab Med; 2016 Jun; 54(6):1005-14. PubMed ID: 27010775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical aspects of monoclonal gammopathies in diseases of the lympho-plasmacytic cell system].
    Westerhausen M
    Acta Med Austriaca; 1982; 9(4):143-9. PubMed ID: 6814157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
    Mayo MM; Johns GS
    Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
    Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
    Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
    Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
    Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and immunodiagnostic applications of antihuman light chain monoclonal antibodies.
    Abe M; Goto T; Kennel SJ; Wolfenbarger D; Macy SD; Weiss DT; Solomon A
    Am J Clin Pathol; 1993 Jul; 100(1):67-74. PubMed ID: 7688492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value of the bone marrow plasma cell cytoplasmic light chain ratio in differentiating between multiple myeloma and monoclonal gammopathy of undetermined significance.
    Majumdar G; Grace RJ; Singh AK; Slater NG
    Leuk Lymphoma; 1992 Dec; 8(6):491-3. PubMed ID: 1297481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytoplasmic immunoglobulins in bone marrow cells of polyclonal and of monoclonal origin.
    Morell A; Skvaril F; Huser HJ; Spengler G; Barandun S
    Acta Haematol; 1978; 60(3):137-47. PubMed ID: 101001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-neutrophil cytoplasm antibodies in patients with monoclonal gammopathies.
    Esnault VL; Jayne DR; Keogan MT; Brownlee AA; Testa A; Lecarrer D; Brown DL; Lockwood CM
    J Clin Lab Immunol; 1990 Aug; 32(4):153-9. PubMed ID: 1966931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inability of a monoclonal anti-light chain antibody to detect clonal plasma cells in a patient with multiple myeloma by multicolor flow cytometry.
    van Velzen JF; van den Blink D; Bloem AC
    Cytometry B Clin Cytom; 2013; 84(1):30-2. PubMed ID: 23019187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myeloma.
    Preud'Homme JL; Hurez D; Danon F; Brouet JC; Seligmann M
    Clin Exp Immunol; 1976 Sep; 25(3):428-36. PubMed ID: 822974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of IgE myeloma transformed into IgE-producing plasma cell leukaemia.
    Galakhoff N; Leven C; Eveillard JR; Tempescul A; Kerspern H; Aubron C; Buors C; Lippert É; Carré JL; Padelli M
    Biochem Med (Zagreb); 2020 Feb; 30(1):010801. PubMed ID: 31839726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.